Randomized controlled selection trial of cryotherapy vs. compression therapy for the prevention of taxane-induced peripheral neuropathy in breast cancer patients
The CONTRoL Trial: Cryotherapy vs. cOmpression Neuropathy TRiaL (in Breast Cancer Patients)
Sponsor: NIH
Enrolling: Male and Female Patients
IRB Number: AAAR9515
Contact: Research Nurse Navigator: 212-342-5162 / cancerclinicaltrials@cumc.columbia.edu
Additional Study Information: This is a research study of cryotherapy (cold therapy) vs. compression therapy for the prevention of taxane-induced neuropathy. This study will assess the effect of a wearing frozen garments or compression garments on preventing neuropathy pain and discomfort that can be caused by taxane chemotherapy. Cryotherapy involves wearing frozen garments on both hands and feet for 90-120 minutes during the administration of chemotherapy. Compression therapy involves wearing tight-fitting gloves and stockings on both hands and feet for 90-120 minutes during the chemotherapy infusion. Both of these interventions have been shown in clinical trials to reduce the incidence of neuropathy, or a tingling or numbing sensation in the hands and feet, caused by taxane chemotherapy. A control group will wear loose gloves and stockings.
This study is closed
Investigator
Melissa Accordino, MD
Do You Qualify?
Are you at least 21 years of age? Yes No
Do you have a history of breast cancer? Yes No
Will you be receiving paciltaxel or docetaxel for the next 12 weeks? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Research Nurse Navigator
cancerclinicaltrials@cumc.columbia.edu
212-342-5162